Cancer cells downregulate surface antigens to avoid immune recognition and increase the expression and secretion of molecules that enhance immunosuppressive pathways, i.e., cytotoxic T lymphocyte-associated molecule-4 (CTLA-4) and programmed cell death receptor-1 (PD-1)/ligand (PD-L1) [1–3]. Here, CD274 is linked to cancer.